IR, characterized by the diminished sensitivity of insulin-targeting tissues to normal insulin levels, hampers the disposal of insulin-mediated glucose and consequently triggers compensatory hyperinsulinemia [32–35]. This evidence concerns the gene INS and Hyperinsulinemia.